New therapies offer hope for patients with prostate, liver and bile disorders

Patients suffering from prostate enlargement, liver and bile-related disorders now have access to advanced and safer technologies, according to medical experts.

Dr Swapan Sood, Head, Urologist, Andrologist, Kidney Transplant and Robotic Surgeon at Patel Hospital, has introduced Rezum Water Vapour Therapy for prostate enlargement (Benign Prostatic Hyperplasia – BPH). His colleague, Dr Varun Gupta, Gastroenterologist, Hepatologist and Therapeutic Endoscopist, has launched the SpyGlass Endoscopy System for advanced hepatobiliary and pancreatic care.

Dr Sood, supported by Dr Sanyam Nandwani and Dr Kamal Sachdeva, stated that patients can now benefit from a non-surgical, day-care solution for prostate enlargement.

“Rezum uses the natural energy of steam to reduce excess prostate tissue, relieving urinary symptoms without cuts, stitches, or general anaesthesia,” said Dr Sood.

Key benefits of Rezum therapy include its minimally invasive nature, as there are no surgical cuts or stitches required. Patients are discharged the same day. The treatment is also safe for high-risk patients and those unfit for surgery. It preserves sexual function, unlike many surgical alternatives.

He added, “It is a game-changer for men suffering from prostate enlargement. By avoiding general anaesthesia, we can now safely treat even high-risk patients who earlier had no options. It is simple, effective, and restores quality of life quickly.”

Meanwhile, Dr Varun Gupta termed the SpyGlass Direct Visualisation System a breakthrough in diagnosing and treating complex bile duct, pancreatic and liver disorders. “Traditionally, ERCP offered only limited indirect imaging. SpyGlass, however, allows direct, high-resolution visualisation inside the ducts, enabling doctors to identify strictures, stones, or tumours with unmatched accuracy,” he said.

He listed the key benefits of the SpyGlass system: it provides a clear, real-time view of bile and pancreatic ducts; enables precise stone fragmentation, biopsy and treatment; identifies complex conditions missed by conventional scopes; ensures quicker recovery and reduced complications; and allows comprehensive evaluation in a single sitting.

He added, “SpyGlass is transforming how we approach biliary and pancreatic diseases. It gives us direct access and clarity, allowing safer, faster and more accurate treatment.”